Tag Archive | 2endAIDS

Implementation and Other Global Issues

What is still needed to address the HIV/AIDS worldwide? Here Jaime Sepuveda, MD, MPH, PhD, discusses implementation and the need to make the most efficient use of resources for dealing with the epidemic. “We need to understand what is it we do not know,” he said. “We still do not know how much it costs […]

When AIDS Came to Uganda

When AIDS Came to Uganda

More from Moses Kamya, MB, ChB, MMed, MPH, PhD, a professor and chair of the department of medicine at Makerere University in Kampala Uganda, who talks about AIDS and its effect in Uganda. Here he talks about the first case of AIDS he saw in Uganda, a friend and medical student in his class came […]

PEPFAR from a U.S. Perspective

PEPFAR from a U.S. Perspective

In the last video we looked at the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) from the perspective of a doctor in a recipient country. Here we talk to Ambassador Mark Dybul, who co-directs the Global Health Law Program at Georgetown University Law Center’s O’Neill Institute for National and Global Health Law, where he is also a […]

PEPFAR from a Ugandan Perspective

Winding the blog down, it’s worth taking a look at one of the big themes of this meeting: what works. In the case of HIV/AIDS we know treatment and prevention work and we know that one of the most successful examples of this is the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) Here Moses […]

The Need for Global AIDS Activism

More on activism from retired UCSF professor Art Ammann. Here he discusses the need for global activism to confront HIV/AIDS worldwide. “Why is a person going to change their behavior — why is a government going to change its behavior? They’re not going to rudy the literature and go over things and say, “We’re going […]

Support for PEPFAR — Republican or Democrat? (video)

Support for PEPFAR — Republican or Democrat? (video)

This is a snippet from an interview with Steve Morin in which he discusses what is behind the bipartisan support  of PEPFAR, the U.S. President’s Emergency Plan for AIDS Relief. “PEPFAR enjoys strong bipartisan support for a number of reasons,” Morin said. “It responds to a humanitarian need, it is vital to some of our […]

The Future of PEPFAR (video)

This is a snippet from an interview with Paul Volberding in which he discusses the successes, challenges and the future of PEPFAR, the U.S. President’s Emergency Plan for AIDS Relief. “PEPFAR has been an enormously important project of the U.S. government, “Started under George Bush, it has been the vehicle by which the U.S government […]

Should U.S. women use PrEP? Will they?

Should U.S. women use PrEP? Will they?

Although there have been exciting advances in the field of HIV pre-exposure prophylaxis (PrEP) over the past several years, the implications of PrEP for women have been more murky.  Some major PrEP trials have shown efficacy of this strategy in heterosexual African women, but there have been no clinical trials investigating the utility of PrEP […]

How TB and HIV Drugs Interact (video)

Earlier this week Annie Luetkemeyer presented work questioning new FDA guidelines on treating people infected with both HIV and tuberculosis (TB). Here she describes how HIV and TB drugs interact. Background: In January, 2012, the U.S. Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with […]

Preventing TB and Treating HIV-TB Coinfection

A report by Annie Luetkemeyer, MD, assistant clinical professor of medicine, UCSF Division of HIV/AIDS at San Francisco General Hospital and Trauma Center: TB studies in Late Breaker Track B session: Raltegravir in HIV-TB coinfection (THLBB01) and the additive benefit of Isoniazid preventative therapy (IPT) in addition to ART for TB prevent (THLBB03) Raltegravir may be an […]

Follow

Get every new post delivered to your Inbox.

Join 7,356 other followers